Sophia Frangou

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sophia Frangou
Born Athens, Greece
Residence New York City, USA
Nationality British
Fields Psychiatry, Neuroscience
Institutions Icahn School of Medicine at Mount Sinai
Alma mater National and Kapodistrian University of Athens

Sophia Frangou (Greek: Σοφία Φράγκου) is Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai where she heads the Psychosis Research Program. She is a Fellow of the Royal College of Psychiatrists[1] and Vice-Chair of the RCPsych Panamerican Division.[2] She is a Fellow of the European Psychiatric Association (EPA) and of the American Psychiatric Association (APA). She served as Vice-President for Research of the International Society for Bipolar Disordersfrom 2010-2014. She has also served on the Council of the British Association for Psychopharmacology. She is founding member of the EPA NeuroImaging section and founding chair of the Brain Imaging Network of the European College of Neuropsychopharmacology. She is one of the three Editors of European Psychiatry,[3] the official Journal of the European Psychiatric Association.


Frangou graduated from the Medical School of the University of Athens, Greece in 1989. She then moved to the UK where she trained in psychiatry at the Maudsley Hospital, London. She obtained her master's degree in Neuroscience from the University of London, UK and trained in the US as a research fellow at the Department of Psychiatry and Behavioural Sciences at the Johns Hopkins University She returned to the Institute of Psychiatry, King's College London where she completed her PhD on neuroimaging and electrophysiological markers of familial vulnerability to schizophrenia. Between 1997 and 2013 she worked as a Consultant Psychiatrist at the Maudsley Hospital and led her own research group at the Institute of Psychiatry, Psychology and Neuroscience, King's College London.


Frangou's research focuses on the pathophysiological processes underlying psychosis, with emphasis on schizophrenia and bipolar disorder using clinical, genetic, cognitive and neuroimaging techniques. Her key contributions in the field relate to the neuroimaging correlates of disease risk, expression and resilience and on the functional impact of susceptibility genes for schizophrenia and bipolar disorder on brain structure, connectivity and plasticity.

In parallel Frangou is also interested in the standardisation of neuroimaging measures to capture normal variation across the lifespan and to guide diagnosis, prognosis and treatment response. She currently co-chairs the ENIGMA Lifespan Working Group [4] that examines normal variation in brain structure in over 10,000 healthy people aged 2–92 years

Recent publications[edit]

See also[edit]